✦ LIBER ✦

202 Combination chemotherapy with methotrexate, irinotecan, and doxorubicin in malignant pleural mesothelioma: A phase II study

✍ Scribed by Kuribayashi, K.; Fukuoka, K.; Miyake, M.; Miyata, S.; Nakajima, T.; Tamura, K.; Nobuyama, S.; Iida, S.; Uesaka, A.; Yamada, S.; Murakami, A.; Nakano, T.

Book ID: 118573885
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 37 KB
Volume: 54
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(07)70278-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of malignant pleural mesotheli

Treatment of malignant pleural mesothelioma with methotrexate and interferons-Phase II study

✍ Mattson, K.; Halme, M.; Salminen, U-S.; Pyrhönen, S.; Tammilehto, L.; Maasilta, 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 144 KB

199 Sequential topoisomerase targeting t

199 Sequential topoisomerase targeting triplet chemotherapy with irinotecan/cisplatin followed by doxorubicin in patients with malignant pleural mesothelioma: A pilot phase II study

✍ Nakano, T.; Fukuoka, K.; Kuribayashi, K.; Uesaka, A.; Miyata, S.; Miyake, M. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Prospective study of combination chemoth

Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma

✍ Dong M. Shin; Frank V. Fossella; Theera Umsawasdi; William K. Murphy; Marvin H. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

Prospective study of combination chemoth

Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma

✍ Ajay Anand; Abhay Anand; Namrata Anand 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 2 views

mainly located within the cell processes but not within perikarya. The findings thus mimicked those of classic, pediatric neuroblastoma~.~ In contrast, dense core or neurosecretory-type granules in SITA resemble those of enterochromaffin (endocrine) cells of the digestive tract. They are aggregated

Activity of doxorubicin and cisplatin co

Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II study

✍ A. Ardizzoni; R. Rosso; V. Fusco; M. C. Pennucci; L. Santi; F. Salvati; A. Cinqu 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 3 views

Gemcitabine combined with carboplatin in

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma : A multicentric Phase II study

✍ Adolfo G. Favaretto; Savina M. L. Aversa; Adriano Paccagnella; Vincenzo De Pangh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract ## BACKGROUND Malignant pleural mesothelioma (MPM) is increasing rapidly worldwide. Currently, pemetrexed plus cisplatin chemotherapy showed a survival advantage versus cisplatin alone. No impact on patient survival of surgery, radiotherapy, or their combination has been demonstrated.